Cargando…
Comparative analysis of the access to health-care services and breast cancer therapy in 10 Eastern European countries
AIM: The aim of this study is to compare the differences in breast cancer therapy, health-care service practices, and their availability in ten European countries—Albania, Bosnia and Herzegovina, Bulgaria, Kosovo, Montenegro, Republic of North Macedonia, Croatia, Romania, Slovenia, and Republic of S...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249592/ https://www.ncbi.nlm.nih.gov/pubmed/32547747 http://dx.doi.org/10.1177/2050312120922029 |
_version_ | 1783538617949356032 |
---|---|
author | Dimitrova, Maria Lakic, Dragana Petrova, Guenka Bešlija, Semir Culig, Josip |
author_facet | Dimitrova, Maria Lakic, Dragana Petrova, Guenka Bešlija, Semir Culig, Josip |
author_sort | Dimitrova, Maria |
collection | PubMed |
description | AIM: The aim of this study is to compare the differences in breast cancer therapy, health-care service practices, and their availability in ten European countries—Albania, Bosnia and Herzegovina, Bulgaria, Kosovo, Montenegro, Republic of North Macedonia, Croatia, Romania, Slovenia, and Republic of Serbia. METHODS: An inquire survey was conducted among oncologists in the participating countries. The questionnaire was of qualitative character and focused on several key areas as screening practices, diagnosing, treatment, and health-care procedures utilization. The results were processed through comparative and percentage analysis. RESULTS: All of the observed countries have national registries for breast cancer, but only in five, a mechanism of controlled action of early detection is implemented. Ninety percent of the countries have implemented in the national guidelines the European Society of Medical Oncology recommendations, while National Comprehensive Cancer Network is considered in only 50%. In all countries, digital mammography is a universal diagnostic method. Pathohistological analysis, including HER2 receptor expression and determination of the level of progesterone and estrogen receptors, is routinely performed in all countries prior to therapy. Some differences are observed in terms of FISH/CISH methods, determination of Ki-67 volume, and prognostic molecular assays. Trastuzumab is used as neo-adjuvant therapy in HER2-positive disease in all countries, while in Bosnia and Herzegovina and Croatia, only pertuzumab is used. Psychological support is integrated into the professional guidelines for treatment and monitoring in Bosnia and Herzegovina, Bulgaria, and Serbia. CONCLUSIONS: The international guidelines should be followed strictly, and some improvements in the health policies should be made in order to decrease the differences and inequalities in the availability of the breast cancer (BC) health services in the Central and Eastern European countries. |
format | Online Article Text |
id | pubmed-7249592 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-72495922020-06-15 Comparative analysis of the access to health-care services and breast cancer therapy in 10 Eastern European countries Dimitrova, Maria Lakic, Dragana Petrova, Guenka Bešlija, Semir Culig, Josip SAGE Open Med Original Article AIM: The aim of this study is to compare the differences in breast cancer therapy, health-care service practices, and their availability in ten European countries—Albania, Bosnia and Herzegovina, Bulgaria, Kosovo, Montenegro, Republic of North Macedonia, Croatia, Romania, Slovenia, and Republic of Serbia. METHODS: An inquire survey was conducted among oncologists in the participating countries. The questionnaire was of qualitative character and focused on several key areas as screening practices, diagnosing, treatment, and health-care procedures utilization. The results were processed through comparative and percentage analysis. RESULTS: All of the observed countries have national registries for breast cancer, but only in five, a mechanism of controlled action of early detection is implemented. Ninety percent of the countries have implemented in the national guidelines the European Society of Medical Oncology recommendations, while National Comprehensive Cancer Network is considered in only 50%. In all countries, digital mammography is a universal diagnostic method. Pathohistological analysis, including HER2 receptor expression and determination of the level of progesterone and estrogen receptors, is routinely performed in all countries prior to therapy. Some differences are observed in terms of FISH/CISH methods, determination of Ki-67 volume, and prognostic molecular assays. Trastuzumab is used as neo-adjuvant therapy in HER2-positive disease in all countries, while in Bosnia and Herzegovina and Croatia, only pertuzumab is used. Psychological support is integrated into the professional guidelines for treatment and monitoring in Bosnia and Herzegovina, Bulgaria, and Serbia. CONCLUSIONS: The international guidelines should be followed strictly, and some improvements in the health policies should be made in order to decrease the differences and inequalities in the availability of the breast cancer (BC) health services in the Central and Eastern European countries. SAGE Publications 2020-05-20 /pmc/articles/PMC7249592/ /pubmed/32547747 http://dx.doi.org/10.1177/2050312120922029 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Article Dimitrova, Maria Lakic, Dragana Petrova, Guenka Bešlija, Semir Culig, Josip Comparative analysis of the access to health-care services and breast cancer therapy in 10 Eastern European countries |
title | Comparative analysis of the access to health-care services and breast cancer therapy in 10 Eastern European countries |
title_full | Comparative analysis of the access to health-care services and breast cancer therapy in 10 Eastern European countries |
title_fullStr | Comparative analysis of the access to health-care services and breast cancer therapy in 10 Eastern European countries |
title_full_unstemmed | Comparative analysis of the access to health-care services and breast cancer therapy in 10 Eastern European countries |
title_short | Comparative analysis of the access to health-care services and breast cancer therapy in 10 Eastern European countries |
title_sort | comparative analysis of the access to health-care services and breast cancer therapy in 10 eastern european countries |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249592/ https://www.ncbi.nlm.nih.gov/pubmed/32547747 http://dx.doi.org/10.1177/2050312120922029 |
work_keys_str_mv | AT dimitrovamaria comparativeanalysisoftheaccesstohealthcareservicesandbreastcancertherapyin10easterneuropeancountries AT lakicdragana comparativeanalysisoftheaccesstohealthcareservicesandbreastcancertherapyin10easterneuropeancountries AT petrovaguenka comparativeanalysisoftheaccesstohealthcareservicesandbreastcancertherapyin10easterneuropeancountries AT beslijasemir comparativeanalysisoftheaccesstohealthcareservicesandbreastcancertherapyin10easterneuropeancountries AT culigjosip comparativeanalysisoftheaccesstohealthcareservicesandbreastcancertherapyin10easterneuropeancountries |